Abbott Laboratories

ABTNYSE · USD
102.61USD0.00 (+0.38%)
577

Abbott Laboratories (ABT) Implied Volatility Current

ABT implied volatility is 28%. IV Rank is 63%, placing current premiums in the middle of their 52-week range.

Read more

Tracking ABT implied volatility helps you identify when options premiums on Abbott Laboratories are historically cheap or expensive, and where the best trades are hiding. Abbott Laboratories implied volatility reflects the market's expectation of future price movement: when ABT IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Abbott Laboratories's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ABT, tracking metrics like ABT IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ABT signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ABT implied volatility sits today versus where it has been. Our scanner ranks Abbott Laboratories implied volatility against its historical range, surfaces extremes in ABT IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Abbott Laboratories IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
63.49%IV Rank
Moderate

IV is slightly elevated - premiums are richer, leaning toward sellers.

Implied Volatility (30d)28.09%

IV Rank63.49%

Historical Volatility (30d)20.29%

IV - HV+7.80%

As of September 18, 2026

Trade options with IV on your side

Track ABT IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial